SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
False fuel prices in fabricated graphics circulate in Malaysia as Iran war continues - 2The moon and sun figure big in the new year's lineup of cosmic wonders
- 3How federal officials talk about health is shifting in troubling ways – and that change makes me worried for my autistic child
- 4Crew-11 astronauts undock in 1st-ever medical evacuation from the International Space Station (video)
- 5The Response to Independence from the rat race: Methodologies for Creating Financial momentum
- The Incomparable Advanced cameras: Which One Will Win?
- MEPs urge Commission leaders to stop Russia from returning to the Venice Biennale
- Russia’s New KVS Drone May Be Designed To Restore Reach In The FPV War
- One ant for $220: the new frontier of wildlife trafficking
- Old age isn’t a modern phenomenon – many people lived long enough to grow old in the olden days, too
- Step by step instructions to Keep up with Ideal Oral Cleanliness at Home
- Image of foreigners being arrested in S.Africa during Eid is AI-generated
- 'Wicked: For Good' was filmed at this surreal National Park in Egypt
- From Dread to Certainty: Individual Accounts of Strengthening
